Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.

NCT00554086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Escalating dose of Casodex from 50mg daily to 150 mg daily

Sponsor

Canadian Urology Research Consortium

Collaborators

[object Object]